Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium Carbonate for Neurological Outcomes in Carotid Artery Surgery
NCT05126238Phase 3Terminated
- Sponsor
- Negovsky Research Institute of General Reanimatology
- Start
- Nov 2021
- Primary completion
- May 2025
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative delirium (POD) and brain ischemia comparing Lithium with Placebo (2 arms). Primary endpoint: Frequency of emergence delirium at 30 days. Started Nov 2021; status: terminated.
02
Drugs
lithium carbonate
03
Conditions
postoperative delirium (POD)brain ischemia
Beyond the preview
Go deeper on NCT05126238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05126238.